{"id": "Medicine_tweet_13", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Diagnosis and treatment of #oralcancer are assoc w/ changes in sexual behavior, regardless of tumor #HPV status  \"><b>Finding A:</b></span> Diagnosis and treatment of #oralcancer are assoc w/ changes in sexual behavior, regardless of tumor #HPV status  <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Concern over sexual, but not nonsexual, HPV transmission to partners was reported by 50%. Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status. From baseline to 6 months, significant increases in abstinence from vaginal sex (from 10% to 34%; P <.01) and oral sex (from 25% to 80%; P <.01) were reported.\"><b>Finding B:</b></span> Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status.", "label_annotations": {"Level-of-generality": {"Finding A": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 6s "}}
{"id": "Medicine_402", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: With recent support from the Food and Drug Administration on what could be the first-ever approved drug for the treatment of female sexual dysfunction, the researchers believe that HRV could be used as an index of drug-related changes in sexual function. \"Because evidence shows that low HRV is a potential risk factor for sexual dysfunction, physicians have a simple, low-cost and nonintrusive method to measure a woman's risk for sexual dysfunction,\" said Stanton. \"It makes it easier to talk about something a little bit more private and get women the help that they need.\"\"><b>Finding A:</b></span> \"Because evidence shows that low HRV is a potential risk factor for sexual dysfunction, physicians have a simple, low-cost and nonintrusive method to measure a woman's risk for sexual dysfunction,\" said Stanton.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Women with below average HRV were significantly more likely to report sexual arousal dysfunction (p \\ .001) and overall sexual dysfunction (p \\ .001) than both women with average HRV and women with above average HRV. In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction. Given these findings, it is reasonable to expect ANS activity (indexed by HRV) may be related to women's self-reported, real-life sexual arousal function outside of the laboratory.\"><b>Finding B:</b></span> In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction.", "label_annotations": {"Level-of-generality": {"Finding A": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 11s "}}
{"id": "Consent.html", "displayed_text": "Consent", "label_annotations": {"I have read and understood the instructions.": {"Yes": "I have read and understood the instructions.:::Yes"}, "I have read and understood the content warning.": {"Yes": "I have read and understood the content warning.:::Yes"}, "I want to participate in this research and continue with the study.": {"Yes": "I want to participate in this research and continue with the study.:::Yes"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 5s "}}
{"id": "Medicine_104", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: On evenings when using light-emitting tablets, participants' self-selected bedtimes were on average half an hour later, and they showed suppressed melatonin levels, delayed timing of melatonin secretion onset, and later sleep onset. When using the tablets, participants rated themselves as less sleepy in the evenings and less alert in the first hour after awakening on the following mornings. \"These findings provide more evidence that light-emitting electronic devices have biological effects,\" said co-author Dr. Jeanne Duffy, of Brigham and Women's Hospital and Harvard Medical School.\"><b>Finding A:</b></span> On evenings when using light-emitting tablets, participants' self-selected bedtimes were on average half an hour later, and they showed suppressed melatonin levels, delayed timing of melatonin secretion onset, and later sleep onset.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: To our knowledge, this study is the first to quantify the melatonin suppression response to evening light exposure in healthy 3-to 5-year-old children. A combination of well-controlled procedures minimizing sources of error variance, a repeated-measures design, and large effect sizes led to several significant findings: (a) 1-h of bright light exposure before bedtime suppresses melatonin by~88%; (b) the effects of evening bright light exposure on melatonin levels persisted at least 50-min following termination of the light stimulus; and (c) melatonin levels remained attenuated and did not return to 50% of those observed in the dim light condition following the bright light exposure for the majority of the children. Findings from this study mark an important step in addressing a gap in understanding the melatonin suppression response across the lifespan.\"><b>Finding B:</b></span> A combination of well-controlled procedures minimizing sources of error variance, a repeated-measures design, and large effect sizes led to several significant findings: (a) 1-h of bright light exposure before bedtime suppresses melatonin by~88%; (b) the effects of evening bright light exposure on melatonin levels persisted at least 50-min following termination of the light stimulus; and (c) melatonin levels remained attenuated and did not return to 50% of those observed in the dim light condition following the bright light exposure for the majority of the children.", "label_annotations": {"Level-of-generality": {"They are at the same level of generality": "3"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 31s "}}
{"id": "Medicine_401", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: advertisement\n\nPositive behaviours were reported to be much more common than abusive behaviours, however some positive but time-consuming behaviours were notably infrequent. For instance, more than one in three care home staff were rarely aware of a resident being taken outside of the home for their enjoyment, and 15% said activities were almost never planned around a resident's interests. v\"Carers can't just be told that care should be person-centred -- they need to be given the support and training that will enable them to deliver it,\" she said.\"><b>Finding A:</b></span> For instance, more than one in three care home staff were rarely aware of a resident being taken outside of the home for their enjoyment, and 15% said activities were almost never planned around a resident's interests.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Most staff reported positive care behaviours, but specific person-centred activities were sometimes infrequent. Many care home staff were never or almost never aware of a resident being taken out of the home for their enjoyment (34%, n = 520); or an activity planned around a resident's interests (5%, n = 234). 763 (5%; 95% Confidence Interval (CI) 47% to 54%) of care home staff reported carrying out or observing potentially abusive or neglectful behaviours at least sometimes in the preceding 3 months; some abuse was reported as happening \"at least sometimes\" in 9/92 care homes.\"><b>Finding B:</b></span> Many care home staff were never or almost never aware of a resident being taken out of the home for their enjoyment (34%, n = 520); or an activity planned around a resident's interests (5%, n = 234).", "label_annotations": {"Level-of-generality": {"Finding B": "2"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 27s "}}
{"id": "Medicine_3", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Of the 704 patients, 60.7, 31.7, and 7.7 percent reported sufficient, problematic, and inadequate FHL, respectively. The researchers found that the inadequate and problematic FHL groups had a global score of SwQoR that indicated poor recovery (37.4 and 22.9, respectively). The difference in the global score of SwQoR between inadequate and sufficient FHL (37.4 and 17.7) was statistically significant.\"><b>Finding A:</b></span> Of the 704 patients, 60.7, 31.7, and 7.7 percent reported sufficient, problematic, and inadequate FHL, respectively.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Of these patients, 418 (59.4%) were women and 286 (40.6%) were men. Most (n = 427 [60.6%]) of the 704 patients undergoing day surgery reported sufficient FHL, 223 (31.7%) reported problematic FHL, and 54 (7.7%) reported inadequate FHL. There were no statistical differences between the 3 groups in age, sex, type of anesthesia and surgery, or ASA classification ( Table 1) .\"><b>Finding B:</b></span> Most (n = 427 [60.6%]) of the 704 patients undergoing day surgery reported sufficient FHL, 223 (31.7%) reported problematic FHL, and 54 (7.7%) reported inadequate FHL.", "label_annotations": {"Level-of-generality": {"Finding A": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 10s "}}
{"id": "Medicine_71", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: With 19 years of follow-up, Chingford is far and away the largest and longest longitudinal study of first MTP joint OA. Among the 557 symptomatic participants with foot x-rays, the prevalence of radiographic OA of the foot was 16.7%, or roughly one in six - underscoring that it's a common condition. The first MTP joint was the most commonly affected site, with a prevalence of 7.8%, followed by the second cuneometatarsal joint (CMJ) at 6.8%, the talonavicular joint (TNJ) at 5.2%, the navicular first cuneiform joint (NCJ) at 5.2%, and the first CMJ at 3.9%.\"><b>Finding A:</b></span> Among the 557 symptomatic participants with foot x-rays, the prevalence of radiographic OA of the foot was 16.7%, or roughly one in six - underscoring that it's a common condition.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Population prevalence of symptomatic radiographic foot OA Population prevalence estimates were almost identical in the baseline responder population and the total baseline eligible mailed population, hence the latter data are presented. The population prevalence of symptomatic radiographic foot OA in adults aged 50 years and over was 16.7% (95% CI 15.3% to 18.0%). The most commonly affected joint was the 1st MTPJ (7.8%; 95% CI 6.7% to 8.9%), followed by the 2nd CMJ (6.8%; 95% CI 5.7% to 7.8%), TNJ (5.8%; 95% CI 4.8% to 6.9%), NCJ (5.2%; 95% CI 4.0% to 6.4%) and 1st CMJ (3.9%; 95% CI 2.9% to 4.9%) (table 3) .\"><b>Finding B:</b></span> The population prevalence of symptomatic radiographic foot OA in adults aged 50 years and over was 16.7% (95% CI 15.3% to 18.0%).", "label_annotations": {"Level-of-generality": {"Finding A": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 12s "}}
{"id": "Medicine_tweet_68", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: #Vitamin D supplementation during #pregnancy may reduce the risk for underweight babies and fetal or infant mortality. \"><b>Finding A:</b></span> #Vitamin D supplementation during #pregnancy may reduce the risk for underweight babies and fetal or infant mortality. <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: We found that maternal vitamin D supplementation timing, dose, and administration method did not affect cord blood vitamin D concentration. Late vitamin D supplementation (initiation at \u226520 weeks' gestation) improved birth weight, but early supplementation (initiation at <20 weeks' gestation) did not. Most importantly, we found that the lower dose of vitamin D supplementation (\u22642000 IU/d) reduced the risk of fetal or neonatal mortality and SGA, but the higher dose (>2000 IU/d) did not.\"><b>Finding B:</b></span> Late vitamin D supplementation (initiation at \u226520 weeks' gestation) improved birth weight, but early supplementation (initiation at <20 weeks' gestation) did not.", "label_annotations": {"Level-of-generality": {"Finding A": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 11s "}}
{"id": "Generalization Examples.html", "displayed_text": "Generalization Examples", "label_annotations": {"I carefully went over the examples and the instructions.": {"Yes": "I carefully went over the examples and the instructions.:::Yes"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 45s "}}
{"id": "test_question_testing_Finding B", "displayed_text": "<b>Finding A:</b> Magnesium potentially has many health benefits.<br><b>Finding B:</b> This is a test question, please select Finding B.", "label_annotations": {"Level-of-generality": {"Finding B": "2"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 6s "}}
{"id": "Experience.html", "displayed_text": "Experience", "label_annotations": {"How satisfied do you feel about your experience participating in our study?": {"scale_4": "4"}, "Compared to other studies you've participated in, how do you rate the difficulty of this task?": {"scale_3": "3"}, "How confident are you that you performed well in the task?": {"scale_2": "2"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 12s "}}
{"id": "Medicine_268", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: \"Using very large data sets, we have teased out valuable information that will help researchers identify global trends and learn about individual corals,\" says coauthor Vadim Backman, professor of biomedical engineering. \"We want this index to be used to predict how corals might react to future bleaching events. The index will be available online, so that data on corals can be added as they become available, making the tool even more robust.\"><b>Finding A:</b></span> \"We want this index to be used to predict how corals might react to future bleaching events.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: The effect of extrinsic factors P ext was found by correlation between BRI j and taxon-sBRI j (Eqn 17). Because we cannot eliminate effects of intrinsic factors on taxon-sBRI j (e.g., a site may contain mostly bleaching-susceptible coral taxa), P ext is the upper bound of the true variance due to extrinsic factors, and it is expected to increase in accuracy for sites with diverse bleaching responses (i.e., in the limit of a high number of taxa per site n, Eqns 17-19). We estimated the effect of extrinsic factors P ext by correlation between BRI j and taxon-sBRI j (Eqn 17) for sites with two (most conservative estimate) and increasingly higher (n up to 44) numbers of taxa.\"><b>Finding B:</b></span> Because we cannot eliminate effects of intrinsic factors on taxon-sBRI j (e.g., a site may contain mostly bleaching-susceptible coral taxa), P ext is the upper bound of the true variance due to extrinsic factors, and it is expected to increase in accuracy for sites with diverse bleaching responses (i.e., in the limit of a high number of taxa per site n, Eqns 17-19).", "label_annotations": {"Level-of-generality": {"Finding A": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 14s "}}
{"id": "Medicine_tweet_24", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Tamulosin is often used in patients with kidney stones in the hope it will speed stone passage.  This RCT shows it is ineffective.  \"><b>Finding A:</b></span> Tamulosin is often used in patients with kidney stones in the hope it will speed stone passage.  This RCT shows it is ineffective.  <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Findings In this randomized clinical trial of 512 adults, the proportion achieving ureteral stone expulsion by 28 days was 50% with tamsulosin vs 47% with placebo, a nonsignificant difference. Meaning For emergency department patients who present with renal colic owing to ureteral stones smaller than 9 mm, tamsulosin does not appear to promote stone passage. In the 11 cases for which this algorithm did not yield a clear result, the CT scans were individually reviewed and a consensus was reached.\"><b>Finding B:</b></span> Meaning For emergency department patients who present with renal colic owing to ureteral stones smaller than 9 mm, tamsulosin does not appear to promote stone passage.", "label_annotations": {"Level-of-generality": {"Finding A": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 9s "}}
{"id": "Medicine_56", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: The researchers found that there was no statistically significant difference between the two groups in time to the primary end point (a composite of death from cardiovascular causes, nonfatal stroke, and nonfatal heart attack). At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent). Aspirin significantly reduced incidence of nonfatal heart attack and transient ischemic attack, and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization.\"><b>Finding A:</b></span> At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent).<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Patients with an occurrence of nonfatal stroke totaled 114 in the aspirin group and 108 in the no aspirin group; of nonfatal myocardial infarction, 20 in the aspirin group and 38 in the no aspirin group; of undefined cerebrovascular events, 3 in the aspirin group and 5 in the no aspirin group. The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54). Aspirin significantly reduced incidence of nonfatal myocardial infarction (0.30 [95% CI, 0.19-0.47] for aspirin vs 0.58 [95% CI, 0.42-0.81] for no aspirin; HR, 0.53 [95% CI, 0.31-0.91]; P = .02) and transient ischemic attack (0.26 [95% CI, 0.16-0.42] for aspirin vs 0.49 [95% CI, 0.35-0.69] for no aspirin; HR, 0.57 [95% CI, 0.32-0.99]; P = .04), and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization (0.86 [95% CI, 0.67-1.11] for aspirin vs 0.51 [95% CI, 0.37-0.72] for no aspirin; HR, 1.85 [95% CI, 1.22-2.81]; P = .004).\"><b>Finding B:</b></span> The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54).", "label_annotations": {"Level-of-generality": {"Finding B": "2"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 17s "}}
{"id": "Medicine_tweet_1", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Trainees in clinic associated w longer appointment times, even for patients not seen by a trainee. \"><b>Finding A:</b></span> Trainees in clinic associated w longer appointment times, even for patients not seen by a trainee. <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Findings In this single-center cohort study of 49 448 outpatient ophthalmology appointments by 33 attending physicians, appointments with residents and fellows were 32% and 30% longer, respectively, than appointments without trainees. The presence of a trainee in a clinic session was associated with longer mean appointment times, even in appointments in which the trainee was not present. Meaning Academic medical centers face potential challenges in maintaining clinical efficiency and medical education, particularly in emerging value-based reimbursement models.\"><b>Finding B:</b></span> The presence of a trainee in a clinic session was associated with longer mean appointment times, even in appointments in which the trainee was not present.", "label_annotations": {"Level-of-generality": {"Finding B": "2"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 13s "}}
{"id": "Medicine_tweet_298", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Gender Differences in Medical Students' Motives &amp; Career Choice \"><b>Finding A:</b></span> Gender Differences in Medical Students' Motives &amp; Career Choice <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: The finding that men aspire more to surgery specialties and women prefer more often general practice and nonsurgery specialties is consistent with previous research . However, the significance of gender influence, stating the higher aspirations of women for general practice is not very strong (see table 4, Model 1: p = 0.046). In separate analyses of different stages of education this gender influence even disappeared.\"><b>Finding B:</b></span> However, the significance of gender influence, stating the higher aspirations of women for general practice is not very strong (see table 4, Model 1: p = 0.046).", "label_annotations": {"Level-of-generality": {"Finding B": "2"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 16s "}}
{"id": "test_question_testing_Finding A", "displayed_text": "<b>Finding A:</b> Magnesium potentially has many health benefits.<br><b>Finding B:</b> This is a test question, please select Finding A.", "label_annotations": {"Level-of-generality": {"Finding A": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 8s "}}
